BRICS Step Up Pharma Tieups To Promote Innovation
This article was originally published in PharmAsia News
Emerging economies are increasingly looking to each other for drug innovation and access to affordable therapies, underscored by the first ever BRICS pharma innovation forum bringing together regulators, industry and international organizations.
You may also be interested in...
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
With gene editing making the news again after the recent Nobel Prize for CRISPR, China’s EdiGene has been raising new funds to accelerate its pipeline to the clinic, led by a potential one-time cure for thalassemia and helped by recent regulatory changes.